4//SEC Filing
EPIRUS Biopharmaceuticals, Inc. 4
Accession 0001104659-15-075317
CIK 0001135906operating
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 4:37 PM ET
Size
7.3 KB
Accession
0001104659-15-075317
Insider Transaction Report
Form 4
Shea Thomas A.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2015-11-03$1.30/sh+28,926$37,604→ 28,926 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-11-03−28,926→ 20,662 totalExercise: $1.30Exp: 2023-07-08→ Common Stock (28,926 underlying)
Footnotes (2)
- [F1]The option became exercisable with respect to 25% of the shares on June 3, 2014 and with respect to the remaining shares in substantially equal monthly installments over the remaining 3 years.
- [F2]Expiration date corrected from previously reported date of 07/07/2023 to 07/08/2023.
Documents
Issuer
EPIRUS Biopharmaceuticals, Inc.
CIK 0001135906
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001135906
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 4:37 PM ET
- Size
- 7.3 KB